Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Parkinson's Disease, Idiopathic”

Showing 9 of 0 results

Not applicableNot Yet RecruitingNCT07015346
What this trial is testing

Adhesion and Safety of Rotigexole Compared to Neupro®

Who this might be right for
Idiopathic Parkinson Disease
Eva Pharma 40
Testing effectiveness (Phase 2)Study completedNCT00957918
What this trial is testing

Study of NP002 in Subjects With Idiopathic Parkinson's Disease to Treat Dyskinesias Due to Levodopa Therapy

Who this might be right for
Parkinson's Disease
Neuraltus Pharmaceuticals, Inc. 65
Very early researchStudy completedNCT06954662
What this trial is testing

A Targeted Amino Acid Supplement for People With Parkinson's Disease

Who this might be right for
Parkinson Disease, Idiopathic
UConn Health 3
Not applicableUnknownNCT02283073
What this trial is testing

Study for the Early Diagnosis of Parkinson's Disease

Who this might be right for
Parkinson's Disease, Idiopathic
Bio Shai Ltd. 410
Large-scale testing (Phase 3)Study completedNCT01007864
What this trial is testing

Influence of Piribedil (Clarium®) on Vigilance and Cognitive Function in Patients With Parkinson's Disease Compared to Other Non-Ergot Dopamine Agonists

Who this might be right for
Idiopathic Parkinson's Disease
Desitin Arzneimittel GmbH 80
Not applicableUnknownNCT02045420
What this trial is testing

Vascular Abnormalities in Idiopathic Parkinson's Disease

Who this might be right for
Idiopathic Parkinson's Disease
University of Saskatchewan 30
Testing effectiveness (Phase 2)Study completedNCT00407212
What this trial is testing

Three Doses of TCH346 in Patients With Early Parkinson's Disease to Evaluate Safety and Efficacy

Who this might be right for
Parkinson's Disease
Novartis 301
Post-approval studies (Phase 4)Study completedNCT01782222
What this trial is testing

Trial to Evaluate The Efficacy Of Rotigotine on Parkinson's Disease-Associated Motor Symptoms And Apathy

Who this might be right for
Idiopathic Parkinson's Disease
UCB BIOSCIENCES GmbH 122
Not applicableStudy completedNCT00599339
What this trial is testing

Transdermal Rotigotine User Surveillance Study

Who this might be right for
Idiopathic Parkinson Disease
UCB Pharma 2,195

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation